Relay Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Relay Therapeutics, a biotech company dedicated to developing breakthrough medicines by leveraging insights from protein motion, today announced that Sanjiv Patel, M.D., President and Chief Executive Officer, will present at Cowen and Company’s 38th Annual Health Care Conference.

The presentation will take place on Monday, March 12, 2018 at 4:00 p.m. Eastern Time at the Boston Marriott Copley Place in Boston, MA.

Relay Therapeutics is committed to discovering and developing medicines that will make a transformative difference for patients by building the first dedicated drug discovery pipeline centered on protein motion. Bringing together the latest scientific advances in structural biology, biophysics, computation, chemistry and biology, Relay’s drug discovery engine illuminates the full mobility of a protein and the ways in which protein motion regulates function. By applying this approach and by focusing on disease-causing targets, Relay aims to develop breakthrough medicines for patients in need. The company’s initial programs are focused on developing therapeutics in oncology. Headquartered in Cambridge, Massachusetts, Relay Therapeutics is a private company launched in 2016 and has received funding from leading blue-chip biotechnology investors, including Third Rock Ventures, BVF Partners, GV, Casdin Capital, EcoR1 Capital, Section 32, Alexandria Venture Investments, and an affiliate of D. E. Shaw Research.